Cannady, E. A., Wang, M., Friedrich, S., Rehmel, J. L. F., Yi, P., Small, D. S., . . . Suico, J. G. (2015). Evacetrapib: In vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacol Res Perspect.

Cannady, Ellen A., Ming-Dauh Wang, Stuart Friedrich, Jessica L F. Rehmel, Ping Yi, David S. Small, Wei Zhang, and Jeffrey G. Suico. "Evacetrapib: In vitro and Clinical Disposition, Metabolism, Excretion, and Assessment of Drug Interaction Potential With Strong CYP3A and CYP2C8 Inhibitors." Pharmacol Res Perspect 2015.

Cannady, Ellen A., et al. "Evacetrapib: In vitro and Clinical Disposition, Metabolism, Excretion, and Assessment of Drug Interaction Potential With Strong CYP3A and CYP2C8 Inhibitors." Pharmacol Res Perspect 2015.